Health status of clients receiving methadone maintenance treatment using the SF-36 health survey questionnaire

References

• Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence [seminar]. Lancet 1999; 353: 221 – 6.
   PubMed Web of Science ®Google Scholar
• Ball JC, Ross A. The effectiveness of methadone main- tenance treatment: patients, programmes, services and outcomes. New York: Springer-Verlag, 1991.
   Google Scholar
• McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000; 284: 1689–95.
   Google Scholar
• Rounsaville BJ, Kleber HD. Untreated opiate addicts. How do they differ from those seeking treatment? Arch Gen Psychiatry 1985; 42: 1072–7.
   Google Scholar
• Darke S, Swift W, Hall W. Prevalence, severity and correlates of psychological morbidity among methadone maintenance clients. Addiction 1994; 89: 211–17.
   Google Scholar
• Rounsaville BJ, Weissman MM, Kleber H, Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry 1982; 39: 161–6.
   PubMed Web of Science ®Google Scholar
• Gerstein DR, Harwood HJ, eds. Treating drug problems, Vol. 1: a study of the evolution, financing and effectiveness of public and private drug treatment systems. Washington DC: Institute of Medicine, National Academy Press, 1990: 136–52.
   Google Scholar
• Bell J. Delivering effective methadone treatment. In: Ward J, Mattick RP, Hall W, eds. Opioid maintenance treatment and other opioid replacement therapies. London: Harwood Academic Publishers, 1998: 161–75.
   Google Scholar
• Kemp R, Miller J, Lungley S, Baker M. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations. NZ Med J 1998; 111: 50 – 3.
   PubMed Web of Science ®Google Scholar
• Chetwynd J, Brunton C, Plumridge E, Baldwin D. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme. NZ Med J 1995; 108: 364–6.
   Google Scholar
• Hall W. Perfectionism in the therapeutic appraisal of methadone maintenance [Editorial]. Addiction 1993;88: 1181– 2.
   Google Scholar
• McLellan AT, Kushner H, Metzger D et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9: 199–213.
   Google Scholar
• Darke S, Hall W, Wodak A, Heather N, Ward J. Development and validation of a multi-dimensional instru- ment for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict 1992;87: 733– 42.
   Google Scholar
• Marsden J, Gossop M, Stewart D et al. The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction 1998; 93: 1857–68.
   Google Scholar
• Sanderson K, Andrews G. Prevalence and severity of mental health-related disability and relationship to diagnosis. Psychiatr Serv 2002; 53: 80–6.
   Google Scholar
• McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form health survey: II Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1992; 30: 475–83.
   Google Scholar
• Ware JE, Snow KK, Kosinski, M, Gandek B. SF-36 health survey. Manual and interpretation guide. Boston, MA: The Health Institute, 1993.
   Google Scholar
• Ministry of Health. Taking the pulse. The 1996/97 New Zealand health survey. Wellington: Ministry of Health, 1999.
   Google Scholar
• Scott KM, Tobias MI, Sarfati D, Haslett SJ. SF-36 health survey reliability, validity and norms for New Zealand. Aust NZ J Public Health 1999; 23: 401–6.
   Google Scholar
• Volk RJ, Cantor SB, Steinbauer JR, Cass AR. Alcohol use disorders, consumption patterns, and health-related quality of life of primary care patients. Alcohol Clin Exp Res 1997; 21: 899 – 905.
   PubMed Web of Science ®Google Scholar
• Rooney S, Freyne A, Kelly G, O’Connor J. Differences in the quality of life of two groups of drug users. Ir J Psych Med 2002; 19: 55–9.
   PubMedGoogle Scholar
• White JM, Danz C, Kneebone J, La Vincente SF, New- combe DA, Ali RL. Relationship between LAAM-metha- done preference and treatment outcomes. Drug Alcohol Depend 2002; 66: 295–301.
   Google Scholar
• Perneger TV, Giner F, del Rio M, Mino A. Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. Br Med J 1998;317: 13– 18.
   Google Scholar
• Ryan CF, White JM. Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire. Addiction 1996; 91: 39–45.
   Google Scholar
• White JM, Ryan CF, Ali RL. Use of the SF-36 to monitor improvements in the health of methadone maintenance participants. In: Harris I, ed. Problems of drug dependence. Rockville: NIDA Research Monograph, 1996:164.
   Google Scholar
• Torrens M, Luis S, Martinez A, Castillo C, Domingo- Salvany A, Alonso J. Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction 1997; 92: 707–16.
   Google Scholar
• Mackinnon S, Paton-Simpson G. Routine outcome measurement in methadone maintenance—feasibility and potential benefits. CIRU report. Auckland: Regional Alco- hol and Drug Services Clinical Information and Research Unit, 1999.
   Google Scholar
• Broughton J. Being Maori. NZ Med J 1993; 106: 506–8.
   Google Scholar
• Sobell LC, Sobell MB. Timeline followback users guide: a calendar method for assessing alcohol and drug use. Toronto: Addiction Research Foundation, 1996.
   Google Scholar
• Fals-Stewart W, O’Farrell TJ, Freitas TT, McFarlin SK, Rutigliano P. The timeline followback reports of psychoac- tive substance use by drug abusing patients: psychometric properties. J Consult Clin Psychol 2000; 64: 134–44.
   Google Scholar
• MacEwan I. Upper limits for responsible drinking. ALAC Report of the Working Party on Upper Limits for Responsible Drinking. Wellington: Alcohol Advisory Coun- cil of New Zealand, 1995.
   Google Scholar
• Sullivan PF, Builik CM. Mood disorders. In: Ellis PM, Collings SC, eds. Mental Health in New Zealand from a Public Health Perspective. Wellington: Ministry of Health, 1997: 267–84.
   Google Scholar
• Bushnell J. Anxiety disorders. In: Ellis PM, Collings SC, eds. Mental health in New Zealand from a public health perspective. Wellington: Ministry of Health, 1997: 285–93.
   Google Scholar
• Darke S, Swift W, Hall W, Ross M. Drug use, HIV risk- taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients. Drug Alcohol Depend 1993; 34: 67–70.
   Google Scholar
• Darke S. The effectiveness of methadone maintenance treatment 3. Moderators of treatment outcome. In: Ward J, Mattick RP, Hall W, eds. Opioid maintenance treatment and other opioid replacement therapies. London: Harwood Academic Publishers, 1998: 75–89.
   Google Scholar
• Epstein DH, Preston KL. Does cannabis use predict poor outcome for heroin dependent patients on maintenance treatment? Past findings and more evidence against. Addiction 2003; 98: 269–79.
   Google Scholar
• Richter KP, Ahluwalia JS. A case for addressing cigarette use in methadone and other opioid treatment programmes. J Addict Dis 2000; 19: 35–52.
   Google Scholar
• Scott KM, Sarfati D, Tobias MI, Haslett SJ. A challenge to the cross-cultural validity of the SF-36 health survey: factor structure in Maori, Pacific and New Zealand European ethnic groups. Soc Sci Med 2000; 51: 1655–64.
   Google Scholar